Guidelines for mass screening of congenital hypothyroidism (2014 revision)

Clinical Pediatric Endocrinology

Volumn 24, Issue 3, 2015, Pages 107-133

  Nagasaki, Keisuke ^a   Minamitani, Kanshi ^b   Anzo, Makoto ^c   Adachi, Masanori ^d   Ishii, Tomohiro ^e   Onigata, Kazumichi ^f   Kusuda, Satoshi ^f   Harada, Shohei ^g   Horikawa, Reiko ^g   Minagawa, Masanori ^h   Mizuno, Haruo ⁱ   Yamakami, Yuji ^j   Fukushi, Masaru ^k   Tajima, Toshihiro ^l  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b TEIKYO UNIVERSITY CHIBA MEDICAL CENTER   (Japan)

^c KAWASAKI MUNICIPAL HOSPITAL   (Japan)

^d KANAGAWA CHILDREN'S MEDICAL CENTER   (Japan)

^e KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f SHIMANE UNIVERSITY HOSPITAL   (Japan)

^g NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^h CHIBA CHILDREN'S HOSPITAL   (Japan)

ⁱ NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^j Kanagawa Health Service Association   (Japan)

^k Apporo IDL   (Japan)

^l HOKKAIDO UNIVERSITY   (Japan)

more..

Author keywords

Congenital hypothyroidism; Guideline; Mass screening

Indexed keywords

LEVOTHYROXINE; THYROTROPIN; THYROXINE;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ADOLESCENCE; ARTICLE; BODY HEIGHT; CARDIOVASCULAR MALFORMATION; CLINICAL EVALUATION; CONGENITAL HYPOTHYROIDISM; DIAGNOSTIC IMAGING; DISEASE COURSE; DISEASE SEVERITY; DRUG MONITORING; ECHOGRAPHY; FAMILY HISTORY; FERTILITY; GENETIC COUNSELING; HORMONE DETERMINATION; HUMAN; IODINE DEFICIENCY; LOW BIRTH WEIGHT; MASS SCREENING; MEDICAL HISTORY; NEWBORN SCREENING; PRACTICE GUIDELINE; PREMATURITY; PROGNOSIS; PSYCHOMOTOR DEVELOPMENT; PSYCHOMOTOR DISORDER; SUBCLINICAL HYPOTHYROIDISM; THYROID FUNCTION TEST; THYROID SCINTISCANNING; TRANSIENT INFANTILE HYPERTHYROTROPINEMIA;

EID: 84937831450     PISSN: 09185739     EISSN: 13477358     Source Type: Journal    
DOI: 10.1297/cpe.24.107     Document Type: Article

References (140)

1. Rastogi MV, LaFranchi SH. Congenital hypothyroidism. Orphanet J Rare Dis. 2010 10;5:17. doi: 10.1186/1750-1172-5-17.
2. Grosse SD, Van Vliet G. Prevention of intellectual disability through screening for congenital hypothyroidism: how much and at what level? Arch Dis Child 2011;96: 374-9. [Medline] [CrossRef]
3. Nakajima H, Satoh K, Inomata H, Matsuura N, Igarashi H, et al. National study of mental development of patients with congenital hypothyroidism disclosed by neonatal mass screening. J Jpn Pediatr Soc 1989;93: 2011-6 (in Japanese).
4. Niimi H. Neonatal screening for congenital hypothyrodism and hyperthyrotropinemia without hypothyroxinemia. Clin Pediatr Endocrinol 1994;3: 73-7. [CrossRef]
5. Inomata H, Aoki K. National survey of congenital hypothyroidism detected by neonatal mass screening (1994-1999). Jpn J Mass Screening 2003;13: 27-32 (in Japanese).
6. Inomata H, Matsuura N, Tachibana K, Kusuda S, Fukushi M, Umehashi T, et al. Guideline of congenital hypothyroidism in neonatal mass screening (1998). J Jpn Pediatr Soc 1998;102: 817-8 (in Japanese).
7. Inomata H, Matsuura N, Tachibana K, Kusuda S, Fukushi M, Umehashi H, et al. Guideline for neonatal mass-screening for congenital hypothyroidism (1998). Clin Pediatr Endocrinol 1999;8: 51-5. [CrossRef]
8. Gu YH, Kato T, Harada S, Inomata H, Aoki K. Time trend and geographic distribution of treated patients with congenital hypothyroidism relative to the number of available endocrinologists in Japan. J Pediatr 2010;157: 153-7. [Medline] [CrossRef]
9. Nagasaki K, Asami T, Ogawa Y, Kikuchi T, Uchiyama M. A study of the etiology of congenital hypothyroidism in the Niigata prefecture of Japan in patients born between 1989 and 2005 and evaluated at ages 5-19. Thyroid 2011;21: 361-5. [Medline] [CrossRef]
10. Rose SR, Brown RS, Foley T, Kaplowitz PB, Kaye CI, Sundararajan S, et al. American Academy of Pediatrics Section on Endocrinology and Committee on Genetics, American Thyroid Association Public Health Committee, Lawson Wilkins Pediatric Endocrine Society Update of newborn screening and therapy for congenital hypothyroidism. Pediatrics 2006;117: 2290-303. [Medline] [CrossRef]
11. Working Group on Neonatal Screening of the European Society for Paediatric Endocrinology Revised guidelines for neonatal screening programmes for primary congenital hypothyroidism. Horm Res 1999;52: 49-52. [Medline] [CrossRef]
12. Léger J, Olivieri A, Donaldson M, Torresani T, Krude H, van Vliet G, et al. ESPE-PESSLEP-JSPE-APEG-APPES-ISPAE Congenital Hypothyroidism Consensus Conference Group European Society for Paediatric Endocrinology consensus guidelines on screening, diagnosis, and management of congenital hypothyroidism. J Clin Endocrinol Metab 2014;99: 363-84. [Medline] [CrossRef]
13. Köhler B, Schnabel D, Biebermann H, Gruters A. Transient congenital hypothyroidism and hyperthyrotropinemia: normal thyroid function and physical development at the ages of 6-14 years. J Clin Endocrinol Metab 1996;81: 1563-7. [Medline]
14. Harada S, Ichihara N, Fujieda K, Okuno A. Etiological classification of transient neonatal thyroid dysfunction detected by neonatal mass screening for congenital hypothyroidism. J Jpn Pediatr Soc 1995;99: 1079-85 (in Japanese).
15. Calaciura F, Motta RM, Miscio G, Fichera G, Leonardi D, Carta A, et al. Subclinical hypothyroidism in early childhood: a frequent outcome of transient neonatal hyperthyrotropinemia. J Clin Endocrinol Metab 2002;87: 3209-14. [Medline] [CrossRef]
16. Moreno JC, Bikker H, Kempers MJ, van Trotsenburg AS, Baas F, de Vijlder JJ, et al. Inactivating mutations in the gene for thyroid oxidase 2 (THOX2) and congenital hypothyroidism. N Engl J Med 2002;347: 95-102. [Medline] [CrossRef]
17. Maruo Y, Takahashi H, Soeda I, Nishikura N, Matsui K, Ota Y, et al. Transient congenital hypothyroidism caused by biallelic mutations of the dual oxidase 2 gene in Japanese patients detected by a neonatal screening program. J Clin Endocrinol Metab 2008;93: 4261-7. [Medline] [CrossRef]
18. Satoh M, Aso K, Ogikubo S, Ogasawara A, Saji T. Genetic analysis in children with transient thyroid dysfunction or subclinical hypothyroidism detected on neonatal screening. Clin Pediatr Endocrinol 2009;18: 95-100. [Medline] [CrossRef]
19. Gaudino R, Garel C, Czernichow P, Léger J. Proportion of various types of thyroid disorders among newborns with congenital hypothyroidism and normally located gland: a regional cohort study. Clin Endocrinol (Oxf) 2005;62: 444-8. [Medline] [CrossRef]
20. Matsuura N, Harada S, Ohyama Y, Shibayama K, Fukushi M, Ishikawa N, et al. The mechanisms of transient hypothyroxinemia in infants born to mothers with Graves' disease. Pediatr Res 1997;42: 214-8. [Medline] [CrossRef]
21. Matsuura N, Yamada Y, Nohara Y, Konishi J, Kasagi K, Endo K, et al. Familial neonatal transient hypothyroidism due to maternal TSHbinding inhibitor immunoglobulins. N Engl J Med 1980;303: 738-41. [Medline] [CrossRef]
22. Nagasaki K, Asami N, Nomura M, Hokari M, Otabe N. A study of maternal TSH receptor blocking antibody in screening positive cases for congenital hypothyroidism. Jpn J Mass Screening 2011;21: 227-31 (in Japanese).
23. Delange F, Dalhem A, Bourdoux P, Lagasse R, Glinoer D, Fisher DA, et al. Increased risk of primary hypothyroidism in preterm infants. J Pediatr 1984;105: 462-9. [Medline] [CrossRef]
24. Srinivasan R, Harigopal S, Turner S, Cheetham T. Permanent and transient congenital hypothyroidism in preterm infants. Acta Paediatr 2012;101: e179-82. [Medline] [CrossRef]
25. Harada S, Ichihara N, Fujieda K. Preterm infants with thyroid dysfunction detected by neonatal mass screening for congenital hypothyroidism. J Jpn Pediatr Soc 1994;98: 2000-7 (in Japanese).
26. Harada S, Ichihara N, Matsuura N, Fujieda K, Fukushi M, Kikuchi Y. Usefulness to determine urinary iodine in infants refereed to medical examination on neonatal screening for congenital hypothyroidism. J Jpn Pediatr Soc 1998;99: 1924-31 (in Japanese).
27. Nishiyama S, Mikeda T, Okada T, Nakamura K, Kotani T, Hishinuma A. Transient hypothyroidism or persistent hyperthyrotropinemia in neonates born to mothers with excessive iodine intake. Thyroid 2004;14: 1077-83. [Medline] [CrossRef]
28. Arata N, Harada S. Neonatal hypothyroidism affected by maternal health condition. Jpn J Pediatr Med 2007;39: 713-6 (in Japanese).
29. Oda Y, Mafune R, Shibamura M, Sasano A, Horie A, Kojima A, et al. Effect of hysterosalpingography on thyroid function in neonates. Folia Endocrinol Jpn 2012;88(Suppl): 28-30 (in Japanese).
30. Zamproni I, Grasberger H, Cortinovis F, Vigone MC, Chiumello G, Mora S, et al. Biallelic inactivation of the dual oxidase maturation factor 2 (DUOXA2) gene as a novel cause of congenital hypothyroidism. J Clin Endocrinol Metab 2008;93: 605-10. [Medline] [CrossRef]
31. Calaciura F, Mendorla G, Distefano M, Castorina S, Fazio T, Motta RM, et al. Childhood IQ measurements in infants with transient congenital hypothyroidism. Clin Endocrinol (Oxf) 1995;43: 473-7. [Medline] [CrossRef]
32. Azizi F, Afkhami M, Sarshar A, Nafarabadi M. Effects of transient neonatal hyperthyrotropinemia on intellectual quotient and psychomotor performance. Int J Vitam Nutr Res 2001;71: 70-3. [Medline] [CrossRef]
33. Harada S, Matsuura N, Fujieda K, Ooyanagi K, Okuno T, Ichihara N, et al. Subclinical hypothyroidism detected by neonatal mass screening. Clin Endocrinol (Oxf) 1991;39: 1063-8 (in Japanese).
34. Harada S, Ichihara N, Arai J. Later manifestation of congenital hypothyroidism predicted by slightly elevated thyrotropin levels in neonatal screening. Screening 1995;3: 181-92. [CrossRef]
35. Daliva AL, Linder B, DiMartino-Nardi J, Saenger P. Three-year follow-up of borderline congenital hypothyroidism. J Pediatr 2000;136: 53-6. [Medline] [CrossRef]
36. Leonardi D, Polizzotti N, Carta A, Gelsomino R, Sava L, Vigneri R, et al. Longitudinal study of thyroid function in children with mild hyperthyrotropinemia at neonatal screening for congenital hypothyroidism. J Clin Endocrinol Metab 2008;93: 2679-85. [Medline] [CrossRef]
37. Harada S. Subclinical congenital hypothyroidism. Jpn J Mass Screening 2004;12: 39 (Abstract) (in Japanese).
38. Harada S, Matsuura N, Shibayama K. Guideline of subclinical congenital hypothyroidism. Annual report. Development of effective mass screening from the Ministry of Health, Labor and Welfare Project on Intractable Disease. 2000. p. 43-47 (in Japanese).
39. Krude H, Blankenstein O. Treating patients not numbers: the benefit and burden of lowering TSH newborn screening cut-offs. Arch Dis Child 2011;96: 121-2. [Medline] [CrossRef]
40. Nishiyama S, Monozono N, Hishinuma A, Tajiri J, Kishiwaki H, Nakamura K, et al. Evaluation of subclinical hypothyroidism by uruinary iodine concentration in children. J Jpn Pediatr Soc 2000;110: 912-8 (in Japanese).
41. Tabuchi M, Nose O, Miki K, Miyai K, Hata N. Prognosis of transient hyper TSH in infants. Research for mass screening. Development of effective mass screening from the Ministry of Health and Welfare Project on mentally and physically handicapped children. 1985. p. 147-9 (in Japanese).
42. Minamitani K, Inomata H. Neonatal screening for congenital hypothyroidism in Japan. Pediatr Endocrinol Rev 2012;10(Suppl 1): 79-88. [Medline]
43. Nakajima H, Makino S. Cretinism in Japan (before mass screening). Pediatrics 1980;21: 65-71 (in Japanese).
44. Fukushi M. Screening for congenital hypothyroidism. Laboratory science of neonatal mass screening (Suppl) 2000. p.12-19 (in Japanese).
45. Inomata H, Nakajima H, Satoh K. Nation study of mental development of patients with congenital hypothyroidism detected by neonatal mass screening in Japan. Reevaluation of IQ score with WISC-R revised in 1989. J Jpn Pediatr Soc 1991;95: 2336-9 (in Japanese).
46. Inomata H, Nakajima H, Satoh K, Oonishi H, Niimi H. Nation study of mental development of patients with congenital hypothyroidism detected by neonatal mass screening in Japan. Results in the second and total nationwide studies. J Jpn Pediatr Soc 1994;98: 33-8 (in Japanese).
47. Inomata H, Kuroda Y. Mental development of patients with congenital hypothyroidism detected by neonatal mass screening for congenital hypothyroidism. The third nationwide study. Research for children and families. 2001. p. 487-9 (in Japanese).
48. LaFranchi SH. Approach to the diagnosis and treatment of neonatal hypothyroidism. J Clin Endocrinol Metab 2011;96: 2959-67. [Medline] [CrossRef]
49. Niimi H, Kamitaki H. Questionaries' survey for cut off values of congenital hypothyroidism in neonatal mass screening. Development of new mass screening from the Ministry of Health and Welfare Project on mentally and physically handicapped children. 1996. p. 149-51 (in Japanese).
50. Minamitani K, Sugihara S, Inomata H, Harada S. Reevaluation of neonatal screening system for congenital hypothyroidism. Jpn J Mass Screening 2009;19: 51-7 (in Japanese).
51. Shima Y, Sugihara S, Matsuoka Y, Ono M, Kashimada K, Urakami T, et al. Study of cut-off value for congenital hypothyroidism screening in Tokyo Metropolitan District. Jpn J Mass Screening 2011;21: 29-35 (in Japanese).
52. Minamitani K, Kashima K, Takatani T, Kinoshita K, Minagawa M, Kamitaki T, et al. Study of sixty-nine patients with congenital hypothyroidism in Chiba prefecture. Clin Endocrinol (Tokyo) 2009;57: 1077-81 (in Japanese).
53. Corbetta C, Weber G, Cortinovis F, Calebiro D, Passoni A, Vigone MC, et al. A 7-year experience with low blood TSH cutoff levels for neonatal screening reveals an unsuspected frequency of congenital hypothyroidism (CH). Clin Endocrinol (Oxf) 2009;71: 739-45. [Medline] [CrossRef]
54. Chiesa A, Prieto L, Papendieck P, Gilligan G, Niremberg M, Gruneiro-Papendieck L. Characterization of thyroid disorders found by primary congenital hypothyroidism (CH) neonatal screening: Something is changing ? Rev Invest Clin 2009;61 (Suppl 1): 30.
55. Korada SM, Pearce M, Ward Platt MP, Avis E, Turner S, Wastell H, et al. Difficulties in selecting an appropriate neonatal thyroid stimulating hormone (TSH) screening threshold. Arch Dis Child 2010;95: 169-73. [Medline] [CrossRef]
56. Harada S, Yuri K, Fujieda K, Matsuura N, Ooyanagki K, Fukushi M, et al. Mass screening for congenital hypothyroidism using free T4 and TSH determination in Sapporo. J Jpn Pediatr Soc 1989;93: 2742-9 (in Japanese).
57. Fukushi M, Fujikura K, Hanai J, Yano K, Tajima T, Fujieda K. Neonatal screening for congenital hypothyroidism by measurement of TSH and free T4. Rev Invest Clin 2009;61 (Suppl 1): 30.
58. Adachi M, Soneda A, Asakura Y, Muroya K, Yamagami Y, Hirahara F. Mass screening of newborns for congenital hypothyroidism of central origin by free thyroxine measurement of blood samples on filter paper. Eur J Endocrinol 2012;166: 829-38. [Medline] [CrossRef]
59. Fujiwara F, Fujikura K, Okuhara K, Tsubaki J, Fukushi M, Fujita K, et al. Central congenital hypothyroidism detected by neonatal mass screening in Sapporo, Japan 2000-2004; Its prevalence and clinical characteristics. Clin Pediatr Endocrinol 2008;17: 65-9. [Medline] [CrossRef]
60. Lanting CI, van Tijn DA, Loeber JG, Vulsma T, de Vijlder JJ, Verkerk PH. Clinical effectiveness and cost-effectiveness of the use of the thyroxine/thyroxine-binding globulin ratio to detect congenital hypothyroidism of thyroidal and central origin in a neonatal screening program. Pediatrics 2005;116: 168-73. [Medline] [CrossRef]
61. Hanna CE, Krainz PL, Skeels MR, Miyahira RS, Sesser DE, LaFranchi SH. Detection of congenital hypopituitary hypothyroidism: ten-year experience in the Northwest Regional Screening Program. J Pediatr 1986;109: 959-64. [Medline] [CrossRef]
62. Hunter MK, Mandel SH, Sesser DE, Miyabira RS, Rien L, Skeels MR, et al. Follow-up of newborns with low thyroxine and nonelevated thyroid-stimulating hormone-screening concentrations: results of the 20-year experience in the Northwest Regional Newborn Screening Program. J Pediatr 1998;132: 70-4. [Medline] [CrossRef]
63. Adachi M. Neonatal screening for congenital hypothyroidism in Japan. Jpn J Mass Screening 2006;16: 27-38 (in Japanese).
64. Inomata H, Nakajima Y, Aoki K, Tachibana K, Kuroda Y. Thirty five patients with congenital hypothyroidism not detected by neonatal mass screening. Clin Endocrinol (Tokyo) 2001;49: 1141-5 (in Japanese).
65. Nagasaki K, Asami N, Otabe N. Four cases of familia1 congenital hypothyroidism undetected by neonatal mass screening. Jpn J Mass Screening 2008;18: 69-72 (in Japanese).
66. Fisher DA. Thyroid function and dysfunction in premature infants. Pediatr Endocrinol Rev 2007;4: 317-28. [Medline]
67. Larson C, Hermos R, Delaney A, Daley D, Mitchell M. Risk factors associated with delayed thyrotropin elevations in congenital hypothyroidism. J Pediatr 2003;143: 587-91. [Medline] [CrossRef]
68. Mitchell ML, Walraven C, Rojas DA, McIntosh KF, Hermos RJ. Screening very-low-birthweight infants for congenital hypothyroidism. Lancet 1994;343: 60-1. [Medline] [CrossRef]
69. Mandel SJ, Hermos RJ, Larson CA, Prigozhin AB, Rojas DA, Mitchell ML. Atypical hypothyroidism and the very low birthweight infant. Thyroid 2000;10: 693-5. [Medline] [CrossRef]
70. Fukushi M. Blood sampling of premature baby in neonatal mass screening. Report of foundation of metabolic screening 1987;10:29 (in Japanese).
71. Kamitaki K, Inomata H. National Survey of Low-birth-weight infants whose diagnosis was not overlooked by two time mass screening test. Jpn J Mass Screening 2002;12: 17-20 (in Japanese).
72. Yamagami Y, Toda M, Fukuda R, Aoki Y, Mori Y, Haruki E, et al. Usefulness of the 2nd examination for congenital hypothyroidism at the neonatal mass screening of low birth weight infants. Jpn J Mass Screening 2003;13: 21-6 (in Japanese).
73. Woo HC, Lizarda A, Tucker R, Mitchell ML, Vohr B, Oh W, et al. Congenital hypothyroidism with a delayed thyroid-stimulating hormone elevation in very premature infants: incidence and growth and developmental outcomes. J Pediatr 2011;158: 538-42. [Medline] [CrossRef]
74. Bijarnia S, Wilcken B, Wiley VC. Newborn screening for congenital hypothyroidism in verylow-birth-weight babies: the need for a second test. J Inherit Metab Dis 2011;34: 827-33. [Medline] [CrossRef]
75. Deming DD, Rabin CW, Hopper AO, Peverini RL, Vyhmeister NR, Nelson JC. Direct equilibrium dialysis compared with two non-dialysis free T4 methods in premature infants. J Pediatr 2007;151: 404-8. [Medline] [CrossRef]
76. Chowdhry P, Scanlon JW, Auerbach R, Abbassi V. Results of controlled double-blind study of thyroid replacement in very low-birth-weight premature infants with hypothyroxinemia. Pediatrics 1984;73: 301-5. [Medline]
77. Smith LM, Leake RD, Berman N, Villanueva S, Brasel JA. Postnatal thyroxine supplementation in infants less than 32 weeks' gestation: effects on pulmonary morbidity. J Perinatol 2000;20: 427-31. [Medline] [CrossRef]
78. van Wassenaer AG, Kok JH, de Vijlder JJ, Briët JM, Smit BJ, Tamminga P, et al. Effects of thyroxine supplementation on neurologic development in infants born at less than 30 weeks' gestation. N Engl J Med 1997;336: 21-6. [Medline] [CrossRef]
79. Yagasaki H, Kobayashi K, Nemoto A, Naito A, Sugita K, Ohyama K. Late-onset circulatory dysfunction after thyroid hormone treatment in an extremely low birth weight infant. J Pediatr Endocrinol Metab 2010;23: 153-8. [Medline]
80. Kawai M, Kusuda S, Cho K, Horikawa R, Takizawa F, Ono M, et al. Nationwide surveillance of circulatory collapse associated with levothyroxine administration in verylow-birthweight infants in Japan. Pediatr Int 2012;54: 177-81. [Medline] [CrossRef]
81. Ohnishi H, Inomata H, Watanabe T, Wataki K, Sato H, Sanayama K, et al. Clinical utility of thyroid ultrasonography in the diagnosis of congenital hypothyroidism. Endocr J 2002;49: 293-7. [Medline] [CrossRef]
82. Niimi H, Kamitaki K, Inomata H, Aoki K. Clinical findings and thyroid function at medical evaluation of patients with congenital hypothyroidism detected by neonatal mass screening. Nationwide study. Research for mass screening. Effective mass screening from the Ministry of Health and Welfare Project on mentally and physically handicapped children. 1998. p. 111-3 (in Japanese).
83. Tamaru K, Inomata H, Sasaki N, Niimi H, Nakajima Y. The size of distal femoral epiphyseal center in congenital hypothyroidism disclosed by neonatal thyroid screening. J Jpn Pediatr Soc 1986;10: 2289-93 (in Japanese).
84. Glorieux J, Desjardins M, Letarte J, Morissette J, Dussault JH. Useful parameters to predict the eventual mental outcome of hypothyroid children. Pediatr Res 1988;24: 6-8. [Medline] [CrossRef]
85. Wasniewska M, De Luca F, Cassio A, Oggiaro N, Gianino P, Delvecchio M, et al. In congenital hypothyroidism bone maturation at birth may be a predictive factor of psychomotor development during the first Year of life irrespective of other variables related to treatment. Eur J Endocrinol 2003;149: 1-6. [Medline] [CrossRef]
86. Selva KA, Mandel SH, Rien L, Sesser D, Miyahira R, Skeels M, et al. Initial treatment dose of L-thyroxine in congenital hypothyroidism. J Pediatr 2002;141: 786-92. [Medline] [CrossRef]
87. Heyerdahl S. Treatment variables as predictors of intellectual outcome in children with congenital hypothyroidism. Eur J Pediatr 1996;155: 357-61. [Medline] [CrossRef]
88. Rovet JF, Ehrlich RM. Long-term effects of L-thyroxine therapy for congenital hypothyroidism. J Pediatr 1995;126: 380-6. [Medline] [CrossRef]
89. Sasaki N, Satoh K, Nakamura N, Kakee N, Harada S. Quality of life of patients with congenital hypothyroidism detected by neonatal mass screening. Research for neonatal mas screening. Research for children and families. 2007. p. 131-6 (in Japanese).
90. Grant DB. Monitoring TSH concentrations during treatment for congenital hypothyroidism. Arch Dis Child 1991;66: 669-70. [Medline] [CrossRef]
91. Abusrewil SS, Tyfield L, Savage DC. Serum thyroxine and thyroid stimulating hormone concentrations after treatment of congenital hypothyroidism. Arch Dis Child 1988;63: 1368-71. [Medline] [CrossRef]
92. Balhara B, Misra M, Levitsky LL. Clinical monitoring guidelines for congenital hypothyroidism: laboratory outcome data in the first year of life. J Pediatr 2011;158: 532-7. [Medline] [CrossRef]
93. Zeitler P, Solberg P, Pharmacy and Therapeutics Committee of the Lawson Wilkins Pediatric Endocrine Society. Food and levothyroxine administration in infants and children. J Pediatr 2010;157: 13-4, e1. [Medline] [CrossRef]
94. Bolk N, Visser TJ, Nijman J, Jongste IJ, Tijssen JG, Berghout A. Effects of evening vs morning levothyroxine intake: a randomized doubleblind crossover trial. Arch Intern Med 2010;170: 1996-2003. [Medline] [CrossRef]
95. Olivieri A, Stazi MA, Mastroiacovo P, Fazzini C, Medda E, Spagnolo A, et al. Study Group for Congenital Hypothyroidism A population-based study on the frequency of additional congenital malformations in infants with congenital hypothyroidism: data from the Italian Registry for Congenital Hypothyroidism (1991-1998). J Clin Endocrinol Metab 2002;87: 557-62. [Medline]
96. Roberts HE, Moore CA, Fernhoff PM, Brown AL, Khoury MJ. Population study of congenital hypothyroidism and associated birth defects, Atlanta, 1979-1992. Am J Med Genet 1997;71: 29-32. [Medline] [CrossRef]
97. Gu YH, Harada S, Kato T, Inomata H, Aoki K, Hirahara F. Increased incidence of extrathyroidal congenital malformations in Japanese patients with congenital hypothyroidism and their relationship with Down syndrome and other factors. Thyroid 2009;19: 869-79. [Medline] [CrossRef]
98. van Trotsenburg AS, Vulsma T, van Santen HM, Cheung W, de Vijlder JJ. Lower neonatal screening thyroxine concentrations in down syndrome newborns. J Clin Endocrinol Metab 2003;88: 1512-5. [Medline] [CrossRef]
99. van Trotsenburg AS, Vulsma T, van Rozenburg-Marres SL, van Baar AL, Ridder JC, Heymans HS, et al. The effect of thyroxine treatment started in the neonatal period on development and growth of two-year-old Down syndrome children: a randomized clinical trial. J Clin Endocrinol Metab 2005;90: 3304-11. [Medline] [CrossRef]
100. Carroll KN, Arbogast PG, Dudley JA, Cooper WO. Increase in incidence of medically treated thyroid disease in children with Down Syndrome after rerelease of American Academy of Pediatrics Health Supervision guidelines. Pediatrics 2008;122: e493-8. [Medline] [CrossRef]
101. Bizhanova A, Kopp P. Genetics and phenomics of Pendred syndrome. Mol Cell Endocrinol 2010;322: 83-90. [Medline] [CrossRef]
102. Yokoro S, Matsuo M, Ohtsuka T, Ohzeki T. Hyperthyrotropinemia in a neonate with normal thyroid hormone levels: the earliest diagnostic clue for pseudohypoparathyroidism. Biol Neonate 1990;58: 69-72. [Medline] [CrossRef]
103. Ohnishi H, Sato H, Noda H, Inomata H, Sasaki N. Color Doppler ultrasonography: diagnosis of ectopic thyroid gland in patients with congenital hypothyroidism caused by thyroid dysgenesis. J Clin Endocrinol Metab 2003;88: 5145-9. [Medline] [CrossRef]
104. Bubuteishvili L, Garel C, Czernichow P, Léger J. Thyroid abnormalities by ultrasonography in neonates with congenital hypothyroidism. J Pediatr 2003;143: 759-64. [Medline] [CrossRef]
105. Perry RJ, Maroo S, Maclennan AC, Jones JH, Donaldson MD. Combined ultrasound and isotope scanning is more informative in the diagnosis of congenital hypothyroidism than single scanning. Arch Dis Child 2006;91: 972-6. [Medline] [CrossRef]
106. Karakoc-Aydiner E, Turan S, Akpinar I, Dede F, Isguven P, Adal E, et al. Pitfalls in the diagnosis of thyroid dysgenesis by thyroid ultrasonography and scintigraphy. Eur J Endocrinol 2012;166: 43-8. [Medline] [CrossRef]
107. Kobayashi H, Tashita H, Hara H, Hasegawa Y. Utility of computed tomography in identifying an ectopic thyroid in infants and pre-school children. Endocr J 2005;52: 189-92. [Medline] [CrossRef]
108. Jones JH, Attaie M, Maroo S, Neumann D, Perry R, Donaldson MD. Heterogeneous tissue in the thyroid fossa on ultrasound in infants with proven thyroid ectopia on isotope scan-a diagnostic trap. Pediatr Radiol 2010;40: 725-31. [Medline] [CrossRef]
109. Panoutsopoulos G, Mengreli C, Ilias I, Batsakis C, Christakopoulou I. Scintigraphic evaluation of primary congenital hypothyroidism: results of the Greek screening program. Eur J Nucl Med 2001;28: 529-33. [Medline] [CrossRef]
110. Schoen EJ, Clapp W, To TT, Fireman BH. The key role of newborn thyroid scintigraphy with isotopic iodide (123I) in defining and managing congenital hypothyroidism. Pediatrics 2004;114: e683-8. [Medline] [CrossRef]
111. Clerc J, Monpeyssen H, Chevalier A, Amegassi F, Rodrigue D, Leger FA, et al. Scintigraphic imaging of paediatric thyroid dysfunction. Horm Res 2008;70: 1-13. [Medline] [CrossRef]
112. Szinnai G, Kosugi S, Derrien C, Lucidarme N, David V, Czernichow P, et al. Extending the clinical heterogeneity of iodide transport defect (ITD): a novel mutation R124H of the sodium/iodide symporter gene and review of genotype-phenotype correlations in ITD. J Clin Endocrinol Metab 2006;91: 1199-204. [Medline] [CrossRef]
113. Eugster EA, LeMay D, Zerin JM, Pescovitz OH. Definitive diagnosis in children with congenital hypothyroidism. J Pediatr 2004;144: 643-7. [Medline] [CrossRef]
114. Parazzini C, Baldoli C, Scotti G, Triulzi F. Terminal zones of myelination: MR evaluation of children aged 20-40 months. AJNR Am J Neuroradiol 2002;23: 1669-73. [Medline]
115. Dimitropoulos A, Molinari L, Etter K, Torresani T, Lang-Muritano M, Jenni OG, et al. Children with congenital hypothyroidism: long-term intellectual outcome after early high-dose treatment. Pediatr Res 2009;65: 242-8. [Medline] [CrossRef]
116. Kempers MJ, van der Sluijs Veer L, Nijhuis-van der Sanden RW, Lanting CI, Kooistra L, Wiedijk BM, et al. Neonatal screening for congenital hypothyroidism in the Netherlands: cognitive and motor outcome at 10 years of age. J Clin Endocrinol Metab 2007;92: 919-24. [Medline] [CrossRef]
117. Rovet JF. Children with congenital hypothyroidism and their siblings: do they really differ? Pediatrics 2005;115: e52-7. [Medline]
118. Léger J, Larroque B, Norton J, Association Française pour le Dépistage et la Prévetion des Handicaps de l'Enfant. Influence of severity of congenital hypothyroidism and adequacy of treatment on school achievement in young adolescents: a population-based cohort study. Acta Paediatr 2001;90: 1249-56. [Medline] [CrossRef]
119. Álvarez M, Iglesias Fernández C, Rodríguez Sánchez A, Dulín Lñiguez E, Rodríguez Arnao MD. Episodes of overtreatment during the first six months in children with congenital hypothyroidism and their relationships with sustained attention and inhibitory control at school age. Horm Res Paediatr 2010;74: 114-20. [Medline] [CrossRef]
120. Asakura Y, Adaci M, Katoh S, Tachibana K. Assessment of emotional and behavioral problems in children screened by neonatal screening for congenital hypothyroidism. J Jpn Pediatr Soc 2006;110: 406-11 (in Japanese).
121. Sato H, Nakamura N, Harada S, Kakee N, Sasaki N. Quality of life of young adults with congenital hypothyroidism. Pediatr Int 2009;51: 126-31. [Medline] [CrossRef]
122. Dickerman Z, De Vries L. Prepubertal and pubertal growth, timing and duration of puberty and attained adult height in patients with congenital hypothyroidism (CH) detected by the neonatal screening programme for CH-a longitudinal study. Clin Endocrinol (Oxf) 1997;47: 649-54. [Medline] [CrossRef]
123. Adachi M, Asakura Y, Tachibana K. Final height and pubertal growth in Japanese patients with congenital hypothyroidism detected by neonatal screening. Acta Paediatr 2003;92: 698-703. [Medline] [CrossRef]
124. Sato H, Sasaki N, Aoki K, Kuroda Y, Kato T. Growth of patients with congenital hypothyroidism detected by neonatal screening in Japan. Pediatr Int 2007;49: 443-6. [Medline] [CrossRef]
125. Salerno M, Micillo M, Di Maio S, Capalbo D, Ferri P, Lettiero T, et al. Longitudinal growth, sexual maturation and final height in patients with congenital hypothyroidism detected by neonatal screening. Eur J Endocrinol 2001;145: 377-83. [Medline] [CrossRef]
126. van der Sluijs Veer L, Kempers MJ, Last BF, Vulsma T, Grootenhuis MA. Quality of life, developmental milestones, and self-esteem of young adults with congenital hypothyroidism diagnosed by neonatal screening. J Clin Endocrinol Metab 2008;93: 2654-61. [Medline] [CrossRef]
127. Léger J, Ecosse E, Roussey M, Lanoë JL, Larroque B, French Congenital Hypothyroidism Study Group. Subtle health impairment and socioeducational attainment in young adult patients with congenital hypothyroidism diagnosed by neonatal screening: a longitudinal population-based cohort study. J Clin Endocrinol Metab 2011;96: 1771-82. [Medline] [CrossRef]
128. Hassani Y, Larroque B, Dos Santos S, Ecosse E, Bouyer J, Léger J. Fecundity in young adults treated early for congenital hypothyroidism is related to the initial severity of the disease: a longitudinal population-based cohort study. J Clin Endocrinol Metab 2012;97: 1897-904. [Medline] [CrossRef]
129. Onigata K. Molecular basis of congenital hypothyroidism. Jpn J Pediatr 2009;62: 1813-21 (in Japanese).
130. Narumi S, Hasegawa T. Molecular mechanism of congenital hypothyroidism. Clin Endocrinol (Tokyo) 2010;7: 565-71 (in Japanese).
131. Castanet M, Polak M, Bonaïti-Pellié C, Lyonnet S, Czernichow P, Léger J, AFDPHE (Association Française pour le Dépistage et la Prévention des Handicaps de l'Enfant) Nineteen years of national screening for congenital hypothyroidism: familial cases with thyroid dysgenesis suggest the involvement of genetic factors. J Clin Endocrinol Metab 2001;86: 2009-14. [Medline] [CrossRef]
132. Léger J, Marinovic D, Garel C, Bonaïti-Pellié C, Polak M, Czernichow P. Thyroid developmental anomalies in first degree relatives of children with congenital hypothyroidism. J Clin Endocrinol Metab 2002;87: 575-80. [Medline] [CrossRef]
133. Grasberger H, Refetoff S. Genetic causes of congenital hypothyroidism due to dyshormonogenesis. Curr Opin Pediatr 2011;23: 421-8. [Medline] [CrossRef]
134. Narumi S, Muroya K, Asakura Y, Adachi M, Hasegawa T. Transcription factor mutations and congenital hypothyroidism: systematic genetic screening of a population-based cohort of Japanese patients. J Clin Endocrinol Metab 2010;95: 1981-5. [Medline] [CrossRef]
135. Narumi S, Muroya K, Asakura Y, Aachi M, Hasegawa T. Molecular basis of thyroid dyshormonogenesis: genetic screening in population-based Japanese patients. J Clin Endocrinol Metab 2011;96: E1838-42. [Medline] [CrossRef]
136. Krude H, Schütz B, Biebermann H, von Moers A, Schnabel D, Neitzel H, et al. Choreoathetosis, hypothyroidism, and pulmonary alterations due to human NKX2-1 haploinsufficiency. J Clin Invest 2002;109: 475-80. [Medline] [CrossRef]
137. Macchia PE, Lapi P, Krude H, Pirro MT, Missero C, Chiovato L, et al. PAX8 mutations associated with congenital hypothyroidism caused by thyroid dysgenesis. Nat Genet 1998;19: 83-6. [Medline] [CrossRef]
138. Hishinuma A, Fukata S, Kakudo K, Murata Y, Ieiri T. High incidence of thyroid cancer in longstanding goiters with thyroglobulin mutations. Thyroid 2005;15: 1079-84. [Medline] [CrossRef]
139. Chertok Shacham E, Ishay A, Irit E, Pohlenz J, Tenenbaum-Rakover Y. Minimally invasive follicular thyroid carcinoma developed in dyshormonogenetic multinodular goiter due to thyroid peroxidase gene mutation. Thyroid 2012;22: 542-6. [Medline] [CrossRef]
140. Mantovani G. Clinical review: Pseudohypoparathyroidism: diagnosis and treatment. J Clin Endocrinol Metab 2011;96: 3020-30. [Medline] [CrossRef]